[시장보고서]세계의 벤조디아제핀계 약제 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)

세계의 벤조디아제핀계 약제 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)

Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1530926

리서치사 : Transparency Market Research

발행일 : 2024년 06월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,627,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 13,093,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,560,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

벤조디아제핀계 약물 시장 - 조사 범위

TMR의 조사 보고서 「벤조디아제핀계 약제 세계 시장」은 2024-2034년까지의 예측 기간에 시장의 지표에 관한 귀중한 통찰을 얻기 위해, 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사했습니다. 본 보고서는 2024년을 기준년, 2034년을 예측년으로 하여 2018-2034년까지 세계의 벤조디아제핀계 약제 시장의 수익과 예측을 제공합니다. 또한 2024-2034년까지 세계의 벤조디아제핀계 약제 시장의 복합 연간 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 벤조디아제핀계 약제 시장을 추찰했습니다.

시장 현황
2023년 시장 규모	22억 달러
2034년 시장 규모	32억 달러
CAGR	3.5%

이 보고서는 세계 벤조디아제핀 계 약물 시장 경쟁 구도를 조사했습니다. 세계의 벤조디아제핀계 약제 시장에서 사업을 전개하는 주요 기업이 확인되어 각 기업이 다양한 속성으로 프로파일 되고 있습니다. 기업 개요, 재무상황, 최근 동향, SWOT 등이 본 보고서에서 소개되고 있는 세계의 벤조디아제핀계 약제시장에서의 진입기업의 속성입니다.

시장 기업-경쟁 매트릭스(기업 Tier과 규모별)
시장 점유율 분석기업별(2023년)
기업 프로파일
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
- Hikma Pharmaceuticals PLC
- H. Lundbeck AS
- Apotex Inc.
- Aurobindo Pharma
- Purdue Pharma
- Other Prominent Players.

JHS

영문 목차

영문목차

Benzodiazepine Drugs Market - Scope of Report

TMR's report on the global benzodiazepine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global benzodiazepine drugs market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global benzodiazepine drugs market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the benzodiazepine drugs market.

Market Snapshot
Market Value in 2023	US$ 2.2 Bn
Market Value in 2034	US$ 3.2 Bn
CAGR	3.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global benzodiazepine drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global benzodiazepine drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global benzodiazepine drugs market.

The report delves into the competitive landscape of the global benzodiazepine drugs market. Key players operating in the global benzodiazepine drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global benzodiazepine drugs market profiled in this report.

Key Questions Answered in Global benzodiazepine drugs Market Report:

What is the sales/revenue generated by benzodiazepine drugs across all regions during the forecast period?
What are the opportunities in the global benzodiazepine drugs market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Benzodiazepine Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global benzodiazepine drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global benzodiazepine drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global benzodiazepine drugs market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Benzodiazepine Drugs Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Benzodiazepine Drugs Market Analysis and Forecasts, 2020-2034
4.5. Porter's Five Force Analysis

5. Key Insights

5.1. Regulatory Scenario by Region/Globally
5.2. Pipeline Analysis
5.3. Overview of Growing Benzodiazepine Drug Misuse
5.4. Impact of COVID-19 Pandemic

6. Global Benzodiazepine Drugs Market Analysis and Forecasts, By Drug Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Drug Type, 2020-2034
- 6.3.1. Alprazolam
- 6.3.2. Clonazepam
- 6.3.3. Diazepam
- 6.3.4. Lorazepam
- 6.3.5. Others (Midazolam, etc.)
6.4. Market Attractiveness By Drug Type

7. Global Benzodiazepine Drugs Market Analysis and Forecasts, By Application

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
- 7.3.1. Anxiety
- 7.3.2. Insomnia
- 7.3.3. Alcohol Withdrawal
- 7.3.4. Seizures
- 7.3.5. Others (Bipolar Disorder, etc.)
7.4. Market Attractiveness By End-user

8. Global Benzodiazepine Drugs Market Analysis and Forecasts, By Time of Action

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Time of Action, 2020-2034
- 8.3.1. Ultra-short Acting
- 8.3.2. Short Acting
- 8.3.3. Long Acting
8.4. Market Attractiveness By Time of Action

9. Global Benzodiazepine Drugs Market Analysis and Forecasts, By End-user

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Hospitals Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Online Pharmacies
9.4. Market Attractiveness By End-user

10. Global Benzodiazepine Drugs Market Analysis and Forecasts, By Region

10.1. Key Findings
10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region

11. North America Benzodiazepine Drugs Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast By Drug Type, 2020-2034
- 11.2.1. Alprazolam
- 11.2.2. Clonazepam
- 11.2.3. Diazepam
- 11.2.4. Lorazepam
- 11.2.5. Others (Midazolam, etc.)
11.3. Market Value Forecast By Application, 2020-2034
- 11.3.1. Anxiety
- 11.3.2. Insomnia
- 11.3.3. Alcohol Withdrawal
- 11.3.4. Seizures
- 11.3.5. Others (Bipolar Disorder, etc.)
11.4. Market Value Forecast By Time of Action, 2020-2034
- 11.4.1. Ultra-short Acting
- 11.4.2. Short Acting
- 11.4.3. Long Acting
11.5. Market Value Forecast By End-user, 2020-2034
- 11.5.1. Hospitals Pharmacies
- 11.5.2. Retail Pharmacies
- 11.5.3. Online Pharmacies
11.6. Market Value Forecast By Country, 2020-2034
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Drug Type
- 11.7.2. By Application
- 11.7.3. By Time of Action
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Benzodiazepine Drugs Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast By Drug Type, 2020-2034
- 12.2.1. Alprazolam
- 12.2.2. Clonazepam
- 12.2.3. Diazepam
- 12.2.4. Lorazepam
- 12.2.5. Others (Midazolam, etc.)
12.3. Market Value Forecast By Application, 2020-2034
- 12.3.1. Anxiety
- 12.3.2. Insomnia
- 12.3.3. Alcohol Withdrawal
- 12.3.4. Seizures
- 12.3.5. Others (Bipolar Disorder, etc.)
12.4. Market Value Forecast By Time of Action, 2020-2034
- 12.4.1. Ultra-short Acting
- 12.4.2. Short Acting
- 12.4.3. Long Acting
12.5. Market Value Forecast By End-user, 2020-2034
- 12.5.1. Hospitals Pharmacies
- 12.5.2. Retail Pharmacies
- 12.5.3. Online Pharmacies
12.6. Market Value Forecast By Country/Sub-region, 2020-2034
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Drug Type
- 12.7.2. By Application
- 12.7.3. By Time of Action
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region

13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Drug Type, 2020-2034
- 13.2.1. Alprazolam
- 13.2.2. Clonazepam
- 13.2.3. Diazepam
- 13.2.4. Lorazepam
- 13.2.5. Others (Midazolam, etc.)
13.3. Market Value Forecast By Application, 2020-2034
- 13.3.1. Anxiety
- 13.3.2. Insomnia
- 13.3.3. Alcohol Withdrawal
- 13.3.4. Seizures
- 13.3.5. Others (Bipolar Disorder, etc.)
13.4. Market Value Forecast By Time of Action, 2020-2034
- 13.4.1. Ultra-short Acting
- 13.4.2. Short Acting
- 13.4.3. Long Acting
13.5. Market Value Forecast By End-user, 2020-2034
- 13.5.1. Hospitals Pharmacies
- 13.5.2. Retail Pharmacies
- 13.5.3. Online Pharmacies
13.6. Market Value Forecast By Country/Sub-region, 2020-2034
- 13.6.1. China
- 13.6.2. India
- 13.6.3. Japan
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Drug Type
- 13.7.2. By Application
- 13.7.3. By Time of Action
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region

14. Latin America Benzodiazepine Drugs Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Drug Type, 2020-2034
- 14.2.1. Alprazolam
- 14.2.2. Clonazepam
- 14.2.3. Diazepam
- 14.2.4. Lorazepam
- 14.2.5. Others (Midazolam, etc.)
14.3. Market Value Forecast By Application, 2020-2034
- 14.3.1. Anxiety
- 14.3.2. Insomnia
- 14.3.3. Alcohol Withdrawal
- 14.3.4. Seizures
- 14.3.5. Others (Bipolar Disorder, etc.)
14.4. Market Value Forecast By Time of Action, 2020-2034
- 14.4.1. Ultra-short Acting
- 14.4.2. Short Acting
- 14.4.3. Long Acting
14.5. Market Value Forecast By End-user, 2020-2034
- 14.5.1. Hospitals Pharmacies
- 14.5.2. Retail Pharmacies
- 14.5.3. Online Pharmacies
14.6. Market Value Forecast By Country/Sub-region, 2020-2034
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Drug Type
- 14.7.2. By Application
- 14.7.3. By Time of Action
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast By Drug Type, 2020-2034
- 15.2.1. Alprazolam
- 15.2.2. Clonazepam
- 15.2.3. Diazepam
- 15.2.4. Lorazepam
- 15.2.5. Others (Midazolam, etc.)
15.3. Market Value Forecast By Application, 2020-2034
- 15.3.1. Anxiety
- 15.3.2. Insomnia
- 15.3.3. Alcohol Withdrawal
- 15.3.4. Seizures
- 15.3.5. Others (Bipolar Disorder, etc.)
15.4. Market Value Forecast By Time of Action, 2020-2034
- 15.4.1. Ultra-short Acting
- 15.4.2. Short Acting
- 15.4.3. Long Acting
15.5. Market Value Forecast By End-user, 2020-2034
- 15.5.1. Hospitals Pharmacies
- 15.5.2. Retail Pharmacies
- 15.5.3. Online Pharmacies
15.6. Market Value Forecast By Country/Sub-region, 2020-2034
- 15.6.1. GCC
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Drug Type
- 15.7.2. By Application
- 15.7.3. By Time of Action
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2023)
16.3. Company Profiles
- 16.3.1. Pfizer Inc.
  - 16.3.1.1. Company Overview
  - 16.3.1.2. Financial Overview
  - 16.3.1.3. Product Portfolio
  - 16.3.1.4. Business Strategies
  - 16.3.1.5. Recent Developments
- 16.3.2. Teva Pharmaceutical Industries Ltd.
  - 16.3.2.1. Company Overview
  - 16.3.2.2. Financial Overview
  - 16.3.2.3. Product Portfolio
  - 16.3.2.4. Business Strategies
  - 16.3.2.5. Recent Developments
- 16.3.3. UCB S.A.
  - 16.3.3.1. Company Overview
  - 16.3.3.2. Financial Overview
  - 16.3.3.3. Product Portfolio
  - 16.3.3.4. Business Strategies
  - 16.3.3.5. Recent Developments
- 16.3.4. Hikma Pharmaceuticals PLC
  - 16.3.4.1. Company Overview
  - 16.3.4.2. Financial Overview
  - 16.3.4.3. Product Portfolio
  - 16.3.4.4. Business Strategies
  - 16.3.4.5. Recent Developments
- 16.3.5. H. Lundbeck AS
  - 16.3.5.1. Company Overview
  - 16.3.5.2. Financial Overview
  - 16.3.5.3. Product Portfolio
  - 16.3.5.4. Business Strategies
  - 16.3.5.5. Recent Developments
- 16.3.6. Apotex Inc.
  - 16.3.6.1. Company Overview
  - 16.3.6.2. Financial Overview
  - 16.3.6.3. Product Portfolio
  - 16.3.6.4. Business Strategies
  - 16.3.6.5. Recent Developments
- 16.3.7. Aurobindo Pharma
  - 16.3.7.1. Company Overview
  - 16.3.7.2. Financial Overview
  - 16.3.7.3. Product Portfolio
  - 16.3.7.4. Business Strategies
  - 16.3.7.5. Recent Developments
- 16.3.8. Purdue Pharma
  - 16.3.8.1. Company Overview
  - 16.3.8.2. Financial Overview
  - 16.3.8.3. Product Portfolio
  - 16.3.8.4. Business Strategies
  - 16.3.8.5. Recent Developments
- 16.3.9. Other Prominent Players.
  - 16.3.9.1. Company Overview
  - 16.3.9.2. Financial Overview
  - 16.3.9.3. Product Portfolio
  - 16.3.9.4. Business Strategies
  - 16.3.9.5. Recent Developments

한글목차

벤조디아제핀계 약물 시장 - 조사 범위

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약: 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : 약제 유형별

제7장 세계 시장 분석과 예측 : 용도별

제8장 세계 시장 분석과 예측 : 작용 시간별

제9장 세계 시장 분석과 예측 : 최종 사용자별

제10장 세계 시장 분석과 예측 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도